Matthew Schabacker's most recent trade in Conmed Corp. was a trade of 17,471 RSUs (Restricted Stock Units) done . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp | Matthew Schabacker | VP GM Advanced Surgical | 02 Mar 2026 | 17,471 | 17,471 | - | - | RSUs (Restricted Stock Units) | ||
| Conmed Corp | Matthew Schabacker | VP GM Advanced Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 11,646 | 11,646 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Matthew Schabacker | VP GM Advanced Surgical | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 9,827 | 9,827 | - | - | RSUs (Restricted Stock Units) | |
| Conmed Corp | Matthew Schabacker | VP GM Advanced Surgical | 28 Apr 2025 | 31,675 | 31,675 | - | - | Options To Purchase Common Stock |